keyword
https://read.qxmd.com/read/38543223/navigating-the-nose-to-brain-route-a-systematic-review-on-lipid-based-nanocarriers-for-central-nervous-system-disorders
#21
REVIEW
Edoardo Agosti, Marco Zeppieri, Sara Antonietti, Luigi Battaglia, Tamara Ius, Caterina Gagliano, Marco Maria Fontanella, Pier Paolo Panciani
BACKGROUND: The blood-brain barrier (BBB) regulates brain substance entry, posing challenges for treating brain diseases. Traditional methods face limitations, leading to the exploration of non-invasive intranasal drug delivery. This approach exploits the direct nose-to-brain connection, overcoming BBB restrictions. Intranasal delivery enhances drug bioavailability, reduces dosage, and minimizes systemic side effects. Notably, lipid nanoparticles, such as solid lipid nanoparticles and nanostructured lipid carriers, offer advantages like improved stability and controlled release...
February 27, 2024: Pharmaceutics
https://read.qxmd.com/read/38540110/novel-interventions-on-comorbidities-in-patients-with-fetal-alcohol-spectrum-disorder-fasd-an-integrative-review
#22
REVIEW
Vicente Andreu-Fernández, Nunzia La Maida, Maribel Marquina, Afrouz Mirahi, Oscar García-Algar, Simona Pichini, Adele Minutillo
Prenatal exposure to alcohol can cause Fetal Alcohol Spectrum Disorders (FASDs) after birth, encompassing a spectrum of physical, cognitive, and behavioral abnormalities. FASD represents a severe non-genetic disability avoidable through alcohol abstinence during pregnancy and when planning it. Clinical severity depends on alcohol impact, symptomatology, and resulting disabilities. FASD is a permanent disability with no recognized specific medical care. Conversely, secondary FASD-related disabilities can be symptomatically treated...
February 22, 2024: Biomedicines
https://read.qxmd.com/read/38537509/functional-electrical-stimulation-combined-with-voluntary-cycling-accentuates-vo-2-response-in-people-with-severe-multiple-sclerosis-a-pilot-study
#23
JOURNAL ARTICLE
Suzanne Máté, Nicholas Corr, Daniel Hackett, Michael Barnett, Maria Fiatarone Singh, Ché Fornusek
BACKGROUND: Lower limb muscle weakness and reduced balance due to disease progression in multiple sclerosis (MS) may make robust aerobic exercise difficult. Functional electrical stimulation (FES) cycling combined with voluntary cycling may allow people with severe MS to enhance the intensity of aerobic exercise. The aim of this study was to investigate the cardiorespiratory, power, and participant-reported perceptions during acute bouts of FES cycling, voluntary cycling, and FES cycling combined with voluntary cycling (FES assist cycling)...
March 20, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38529033/probable-secondary-hemophagocytic-lymphohistiocytosis-manifesting-as-central-nervous-system-lesions-after-covid-19-vaccination-a-case-report
#24
Ju Hye Kim, Ji Yeon Chung, Jeong Bin Bong
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare systemic inflammatory disease commonly characterized by histiocyte infiltration in multiple organs, such as the liver, spleen, lymph nodes, bone marrow, and central nervous system. The clinical features of HLH include fever, splenomegaly, cytopenia, hypertriglyceridemia, hypofibrinogenemia, and elevated blood ferritin levels. HLH is categorized as either primary or secondary. Coronavirus disease 2019 (COVID-19) vaccines may occasionally trigger secondary HLH, which is related to hyperinflammatory syndrome...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38498623/preoperative-11-c-methionine-pet-mri-in-pediatric-infratentorial-tumors
#25
JOURNAL ARTICLE
Pierre-Aurélien Beuriat, Anthime Flaus, Aurélie Portefaix, Alexandru Szathmari, Marc Janier, Marc Hermier, Sylvie Lorthois-Ninou, Christian Scheiber, Sibel Isal, Nicolas Costes, Ines Merida, Sophie Lancelot, Alexandre Vasiljevic, Pierre Leblond, Cécile Faure Conter, Clarisse Saunier, Behrouz Kassai, Matthieu Vinchon, Federico Di Rocco, Carmine Mottolese
PURPOSE: MRI is the main imaging modality for pediatric brain tumors, but amino acid PET can provide additional information. Simultaneous PET-MRI acquisition allows to fully assess the tumor and lower the radiation exposure. Although symptomatic posterior fossa tumors are typically resected, the patient management is evolving and will benefit from an improved preoperative tumor characterization. We aimed to explore, in children with newly diagnosed posterior fossa tumor, the complementarity of the information provided by amino acid PET and MRI parameters and the correlation to histopathological results...
March 25, 2024: Clinical Nuclear Medicine
https://read.qxmd.com/read/38497149/efficacy-of-intravenous-high-dose-methotrexate-in-preventing-relapse-to-the-central-nervous-system-in-r-chop-like-treated-high-risk-diffuse-large-b-cell-lymphoma-patients-and-its-effect-on-mortality-a-systematic-review-and-meta-analysis
#26
JOURNAL ARTICLE
Elisabeth R Tolley, Christian Lewinter, Lars M Pedersen, Torsten Holm Nielsen
UNLABELLED: CNS relapse in patients with diffuse large B-cell lymphoma (DLBCL) carries a dismal prognosis with most clinical guidelines recommending CNS prophylaxis to patients deemed at high risk for CNS relapse. However, results from observational studies investigating the effect of CNS prophylaxis have yielded conflicting results. OBJECTIVES: To evaluate: 1) whether addition of prophylactic intravenous HD-MTX reduces the risk of CNS relapse in high-risk DLBCL patients treated with R-CHOP or similar and 2) whether HD-MTX prophylaxis confers an overall survival benefit, irrespective of CNS relapse...
March 14, 2024: Haematologica
https://read.qxmd.com/read/38490447/genetically-distinct-oligosarcoma-arising-from-oligodendroglioma-systematic-review-illustrative-case-example
#27
JOURNAL ARTICLE
Alexander Evans, Kiana Y Prather, James Battiste, Kar-Ming Fung, Ian F Dunn, Christopher S Graffeo
BACKGROUND: Oligosarcoma is a rare central nervous system (CNS) neoplasm that may arise following oligodendroglioma resection, which demonstrates a unique genetic profile and aggressive clinical phenotype. We present a systematic review and illustrative case example emphasizing the clinical and prognostic features of this unusual and unfavorable neuro-oncologic disease. METHODS: Systematic literature review and illustrative case report. RESULTS: A 41-year-old man who had undergone two neurosurgical resections for a WHO grade II oligodendroglioma (Ki-67=5-10%, 1p/19q co-deleted, IDH2 mutated), without adjuvant chemoradiation, presented with seizures seven years after resection...
March 13, 2024: World Neurosurgery
https://read.qxmd.com/read/38487578/association-between-cns-active-drugs-and-risk-of-alzheimer-s-and-age-related-neurodegenerative-diseases
#28
JOURNAL ARTICLE
Helena Cortes-Flores, Georgina Torrandell-Haro, Roberta Diaz Brinton
OBJECTIVE: As neuropsychiatric conditions can increase the risk of age-related neurodegenerative diseases (NDDs), the impact of CNS-active drugs on the risk of developing Alzheimer's Disease (AD), non-AD dementia, Multiple Sclerosis (MS), Parkinson's Disease (PD) and Amyotrophic Lateral Sclerosis (ALS) was investigated. RESEARCH DESIGN AND METHODS: A retrospective cohort analysis of a medical claims dataset over a 10 year span was conducted in patients aged 60 years or older...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38482514/investigating-the-impact-of-polypharmacy-and-anticholinergic-medication-burden-on-objective-cognitive-performance-in-adults-with-multiple-sclerosis
#29
JOURNAL ARTICLE
Joanie Huebner, Jade Robichaud, Julia S Cozart, Crystal Burkhardt, Sharon G Lynch, Jared M Bruce
BACKGROUND: Polypharmacy, or the use of 5 or more daily medications, is common in adults with multiple sclerosis (MS), and is often due to various physical, cognitive, and emotional symptoms. However, research regarding the association between polypharmacy and cognitive outcomes in MS is sparse. Furthermore, individuals with MS often use medications with anticholinergic properties, which are commonly associated with cognitive impairment and other central nervous system adverse effects...
2024: International Journal of MS Care
https://read.qxmd.com/read/38461731/feasibility-study-to-assess-lesion-repair-in-relapsing-remitting-multiple-sclerosis-a-randomized-controlled-pilot-clinical-trial-of-domperidone-add-on-treatment
#30
JOURNAL ARTICLE
Yunyan Zhang, Wei-Qiao Liu, Zahra Hosseinpour, G Bruce Pike, Graziela Cerchiaro, Jamie Greenfield, V Wee Yong, Luanne M Metz
BACKGROUND: Identification of therapies to promote repair in multiple sclerosis is challenged by the lack of an accepted trial model and associated outcome measures. The goal of this study was to determine the feasibility of a new trial model that enrolls disease modifying therapy (DMT)-treated relapsing-remitting multiple sclerosis (RRMS) participants who have enhancing lesions on clinically indicated brain MRI, and to explore estimates of lesion repair using MRI. METHODS: This was a single site randomized controlled clinical trial...
February 27, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38457005/safety-and-efficacy-of-extended-versus-standard-interval-dosing-of-natalizumab-in-multiple-sclerosis-patients-a-systematic-review-and-meta-analysis
#31
REVIEW
Eslam Mohammed Rabea, Mohamed Mohamed Belal, Abdelrahman H Hafez, Ashraf Hassan Elbanna, Mahmoud Ahmed Khalifa, Anas Zakarya Nourelden, Nada H Mahmoud, Mohamed Sayed Zaazouee
BACKGROUND: Multiple sclerosis (MS) is a chronic inflammatory, immune-mediated disease affecting the central nervous system. Natalizumab, an FDA-approved monoclonal antibody for MS, has been explored for its off-label extended interval dosing (EID), suggesting a potential reduction in the risk of progressive multifocal leukoencephalopathy (PML) compared to standard interval dosing (SID). Our objective was to assess the efficacy and safety of EID in comparison to SID for natalizumab treatment in patients with MS...
March 8, 2024: Acta Neurologica Belgica
https://read.qxmd.com/read/38452648/comparison-of-patient-reported-outcomes-of-physical-activity-and-accelerometry-in-people-with-multiple-sclerosis-and-ambulatory-impairment-a-cross-sectional-study
#32
JOURNAL ARTICLE
Andreas Wanitschek, Barbara Seebacher, Andreas Muehlbacher, Christian Brenneis, Rainer Ehling
BACKGROUND: Accelerometers and patient-reported outcomes (PRO) are used to assess physical activity (PA) in people with multiple sclerosis (pwMS). So far it is unknown, however, whether these assessments represent mobility limitations in pwMS with mild and moderate to severe disability alike. The primary aim of the study was to assess the correlation between accelerometry and International Physical Activity Questionnaire (IPAQ) scores in pwMS with different degrees of ambulatory impairment...
March 1, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38450938/acquired-hypothalamic-obesity-a-clinical-overview-and-update
#33
JOURNAL ARTICLE
Christian L Roth, Shana E McCormack
Hypothalamic obesity (HO) is a rare and complex disorder that confers substantial morbidity and excess mortality. HO is a unique subtype of obesity characterized by impairment in the key brain pathways that regulate energy intake and expenditure, autonomic nervous system function, and peripheral hormonal signalling. HO often occurs in the context of hypothalamic syndrome, a constellation of symptoms that follow from disruption of hypothalamic functions, for example, temperature regulation, sleep-wake circadian control, and energy balance...
March 7, 2024: Diabetes, Obesity & Metabolism
https://read.qxmd.com/read/38434086/the-role-of-short-chain-fatty-acids-in-central-nervous-system-diseases-a-bibliometric-and-visualized-analysis-with-future-directions
#34
JOURNAL ARTICLE
Ziwei Lan, Xiangqi Tang, Ming Lu, Zhiping Hu, Zhenchu Tang
BACKGROUND: Short-chain fatty acids (SCFAs) are thought to play a key role in the microbe-gut-brain axis and involve in the pathogenesis of a variety of neurological diseases. This study aimed to identify research hotspots and evolution trends in SCFAs in central nervous diseases (CNS) and examine current research trends. METHODS: The bibliometric analysis was performed using CiteSpace, and the results were visualized via network maps. RESULTS: From 2002 to 2022, 480 publications in the database met the criteria...
February 29, 2024: Heliyon
https://read.qxmd.com/read/38429713/outcome-measures-in-angelman-syndrome
#35
JOURNAL ARTICLE
Doesjka A Hagenaar, Karen G C B Bindels-de Heus, Maud M van Gils, Louise van den Berg, Leontine W Ten Hoopen, Philine Affourtit, Johan J M Pel, Koen F M Joosten, Manon H J Hillegers, Henriëtte A Moll, Marie-Claire Y de Wit, Gwen C Dieleman, Sabine E Mous
BACKGROUND: Angelman syndrome (AS) is a rare neurodevelopmental disorder characterized by severe intellectual disability, little to no expressive speech, visual and motor problems, emotional/behavioral challenges, and a tendency towards hyperphagia and weight gain. The characteristics of AS make it difficult to measure these children's functioning with standard clinical tests. Feasible outcome measures are needed to measure current functioning and change over time, in clinical practice and clinical trials...
March 1, 2024: Journal of Neurodevelopmental Disorders
https://read.qxmd.com/read/38421132/systems-genetics-analysis-reveals-the-common-genetic-basis-for-pain-sensitivity-and-cognitive-function
#36
JOURNAL ARTICLE
Fuyi Xu, Anran Chen, Shuijing Pan, Yingying Wu, Hongjie He, Zhe Han, Lu Lu, Buyan-Ochir Orgil, XiaoDong Chi, Cunhua Yang, Shushan Jia, Cuicui Yu, Jia Mi
BACKGROUND: There is growing evidence of a strong correlation between pain sensitivity and cognitive function under both physiological and pathological conditions. However, the detailed mechanisms remain largely unknown. In the current study, we sought to explore candidate genes and common molecular mechanisms underlying pain sensitivity and cognitive function with a transcriptome-wide association study using recombinant inbred mice from the BXD family. METHODS: The pain sensitivity determined by Hargreaves' paw withdrawal test and cognition-related phenotypes were systematically analyzed in 60 strains of BXD mice and correlated with hippocampus transcriptomes, followed by quantitative trait locus (QTL) mapping and systems genetics analysis...
February 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38410173/two-cases-of-atypical-teratoid-rhabdoid-tumor-in-the-spinal-cord-loss-of-smarcb1-in-a-child-and-loss-of-smarca4-in-an-adult
#37
Tamaki Morisako, Daisuke Umebayashi, Toshiki Nagai, Takumi Yamanaka, Takanori Hirose, Yukiko Shishido-Hara, Eiich Konishi, Naoya Hashimoto
We compare two cases of primary spinal atypical teratoid/rhabdoid tumor (AT/RT), which rarely occurs in adults marked by SMARCA4 inactivation, and SMARCB1 inactivation for pediatric cases. AT/RT represents a highly malignant neoplasm comprising poorly differentiated constituents and rhabdoid cells, with SMARCB1(INI1) or infrequently SMARCA4 (BRG1) inactivation. These tumors are predominantly found in children but are rare in adults. While AT/RT can arise anywhere in the central nervous system, spinal cord localization is comparatively scarce...
2024: NMC Case Report Journal
https://read.qxmd.com/read/38406222/frequency-and-characteristics-of-chronic-fatigue-syndrome-in-multiple-sclerosis-patients-at-a-university-hospital-in-eastern-saudi-arabia
#38
JOURNAL ARTICLE
Abdullah S AlAmri, Foziah J AlShamrani, Noor M AlMohish, Azra S Zafar, Saud A Alnaaim, Hatem A Alazman, Ibrahim A Al-Ghanimi, Abdullah A AlNahdi, Fahad A AlDawsari, Shahad B AlMatrafi, Ghaida R Alzahrani, Muna S Alnamlah, Rawan A Alkhalifa
BACKGROUND: Multiple sclerosis (MS) is a chronic, inflammatory demyelinating disease that affects various parts of the central nervous system. Fatigue, a common symptom, transient, prolonged, or chronic experienced by individuals with MS, can significantly impact daily functioning. It can be associated with underlying pathological processes or can have an idiopathic cause, such as chronic fatigue syndrome (CFS). The study aimed to assess the presence and etiology of fatigue in MS patients and its relationship with CFS...
2024: Journal of Family & Community Medicine
https://read.qxmd.com/read/38401201/evaluating-the-clinical-utility-of-epstein-barr-virus-antibodies-as-biomarkers-in-multiple-sclerosis-a-systematic-review
#39
REVIEW
Abigail Bose, Farnaz Khalighinejad, David C Hoaglin, Christopher C Hemond
BACKGROUND: EBV is a necessary but not sufficient factor in the pathophysiology of multiple sclerosis (MS). EBV antibodies to the nuclear antigen (EBNA1) and viral capsid antigen (VCA) rise rapidly prior to MS disease manifestations, and their absence has clinical utility with a high negative predictive value. It remains unclear whether EBV levels act as prognostic, monitoring, or pharmacodynamic/response biomarkers. Substantial literature on this topic exists but has not been systematically reviewed...
April 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38395602/readability-of-cerebrovascular-diseases-online-educational-material-from-major-cerebrovascular-organizations
#40
JOURNAL ARTICLE
Avi A Gajjar, Shray Patel, Shrey V Patel, Aditya Goyal, Georgios S Sioutas, Katherine L Gamel, Mohamed M Salem, Visish M Srinivasan, Brian T Jankowitz, Jan Karl Burkhardt
INTRODUCTION: The internet is an essential resource for patients and their loved ones to understand their medical conditions, and professional medical organizations have taken great strides to develop educational material targeting patients. The average American reads at a seventh to eighth grade reading level, hence it is important to understand the readability of this medical information to ensure patients comprehend what is being presented. METHODS: In January 2023, online patient education material was downloaded from major cerebrovascular healthcare organizations and assessed using eight assessments, including Bormuth Cloze Mean, Bormuth Grade Placement, Coleman-Liau (grade levels), Coleman-Liau (predictive cloze scores), Flesch Reading Ease (FRE), and Fry...
February 23, 2024: Journal of Neurointerventional Surgery
keyword
keyword
115034
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.